Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Company Overview

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$0.18 to C$0.19
• 50-Day Range: C$0.14 to C$0.24
• 52-Week Range: C$0.04 to C$0.25
• Volume: 70,500 shs
• Average Volume: 244,362 shs
• Market Capitalization: C$27.27 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VM Stock Analysis - Frequently Asked Questions

How have VM shares performed this year?

Voyageur Pharmaceuticals' stock was trading at C$0.09 at the beginning of 2025. Since then, VM stock has increased by 111.8% and is now trading at C$0.18.
View the best growth stocks for 2025 here.

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Caladrius Biosciences (CLBS), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:VM
• CIK: N/A
• Web: www.voyageurminerals.ca
• Phone: 587-779-6166
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-1,664,938.27
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -117.77%
• Return on Assets: -30.77%

Debt

• Debt-to-Equity Ratio: 4.23
• Current Ratio: 0.10
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 35.00
• Book Value: C$0.01 per share
• Price / Book: 26.57

Miscellaneous

• Outstanding Shares: 151,517,550
• Free Float: N/A
• Market Cap: C$27.27 million
• Optionable: Not Optionable
• Beta: 0.32